Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles

Triple-negative breast cancer (TNBC) is associated with poor survival as chemotherapy is currently limited to conventional cytotoxic agents. Curcumin has promising anticancer actions against TNBC, but its application is hindered by poor bioavailability and rapid degradation in vivo. In the present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kyung-Ho, Lee, Jin Hee, Park, Jin Won, Kim, Da Hae, Moon, Seung-Hwan, Cho, Young Seok, Lee, Kyung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958779/
https://www.ncbi.nlm.nih.gov/pubmed/29805641
http://dx.doi.org/10.3892/ol.2018.8471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958779/
https://www.ncbi.nlm.nih.gov/pubmed/29805641
http://dx.doi.org/10.3892/ol.2018.8471

Ejemplares similares